ConcertAI’s TeraRecon recently announced the EU launch of its Eureka Clinical AI platform, a comprehensive AI solution for imaging analysis spanning neurology, oncology, pulmonology, and cardiology, to European healthcare providers. Combinostics’ cMRI is now available through the platform, along with solutions by six other leading CE-marked AI software developers. cMRI is an AI-driven tool that fully automates brain MRI quantification to provide automated, objective quantification and lesion assessment, as well as biomarker-based diagnostic support for dementia, multiple sclerosis, traumatic brain injury, and epilepsy.
As one of the first EU company partners, this is another a step forward in reaching more clinicians and helping them provide the best possible care for their patients with neurological disorders.
Read more about Eureka Clinical AI and its EU release here.
